BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30039405)

  • 1. Bioguided Design of Trypanosomicidal Compounds: A Successful Strategy in Drug Discovery.
    Álvarez Touron GI
    Methods Mol Biol; 2018; 1824():139-163. PubMed ID: 30039405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Trypanosoma cruzi action of a new benzofuran derivative based on amiodarone structure.
    Pinto-Martinez A; Hernández-Rodríguez V; Rodríguez-Durán J; Hejchman E; Benaim G
    Exp Parasitol; 2018 Jun; 189():8-15. PubMed ID: 29684665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanocidal Activity of Long Chain Diamines and Aminoalcohols.
    Legarda-Ceballos AL; del Olmo E; López-Abán J; Escarcena R; Bustos LA; Fonseca-Berzal C; Gómez-Barrio A; Dib JC; San Feliciano A; Muro A
    Molecules; 2015 Jun; 20(6):11554-68. PubMed ID: 26111182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New 1,3-thiazole derivatives and their biological and ultrastructural effects on Trypanosoma cruzi.
    de Moraes Gomes PAT; de Oliveira Barbosa M; Farias Santiago E; de Oliveira Cardoso MV; Capistrano Costa NT; Hernandes MZ; Moreira DRM; da Silva AC; Dos Santos TAR; Pereira VRA; Brayner Dos Santosd FA; do Nascimento Pereira GA; Ferreira RS; Leite ACL
    Eur J Med Chem; 2016 Oct; 121():387-398. PubMed ID: 27295485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.
    Benaim G; Sanders JM; Garcia-Marchán Y; Colina C; Lira R; Caldera AR; Payares G; Sanoja C; Burgos JM; Leon-Rossell A; Concepcion JL; Schijman AG; Levin M; Oldfield E; Urbina JA
    J Med Chem; 2006 Feb; 49(3):892-9. PubMed ID: 16451055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo trypanosomicidal activity of pyrazole-containing macrocyclic and macrobicyclic polyamines: their action on acute and chronic phases of Chagas disease.
    Sánchez-Moreno M; Marín C; Navarro P; Lamarque L; García-España E; Miranda C; Huertas O; Olmo F; Gómez-Contreras F; Pitarch J; Arrebola F
    J Med Chem; 2012 May; 55(9):4231-43. PubMed ID: 22443115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo trypanosomicidal activity of imidazole- or pyrazole-based benzo[g]phthalazine derivatives against acute and chronic phases of Chagas disease.
    Sánchez-Moreno M; Sanz AM; Gómez-Contreras F; Navarro P; Marín C; Ramírez-Macias I; Rosales MJ; Olmo F; Garcia-Aranda I; Campayo L; Cano C; Arrebola F; Yunta MJ
    J Med Chem; 2011 Feb; 54(4):970-9. PubMed ID: 21229977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triazolopyrimidine compounds containing first-row transition metals and their activity against the neglected infectious Chagas disease and leishmaniasis.
    Caballero AB; Rodríguez-Diéguez A; Quirós M; Salas JM; Huertas Ó; Ramírez-Macías I; Olmo F; Marín C; Chaves-Lemaur G; Gutierrez-Sánchez R; Sánchez-Moreno M
    Eur J Med Chem; 2014 Oct; 85():526-34. PubMed ID: 25127147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The urgent need to develop new drugs and tools for the treatment of Chagas disease.
    Muñoz MJ; Murcia L; Segovia M
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):5-7. PubMed ID: 21171870
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of novel quinine analogs and evaluation of their effects on Trypanosoma cruzi.
    Ceole LF; Gandhi H; Villamizar LH; Soares MJ; O'Sullivan TP
    Future Med Chem; 2018 Feb; 10(4):391-408. PubMed ID: 29380636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parasitology. Drugs to combat tropical protozoan parasites.
    Gelb MH; Hol WG
    Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
    [No Abstract]   [Full Text] [Related]  

  • 13. Clear Shot at Primary Aim: Susceptibility of Trypanosoma cruzi Organelles, Structures and Molecular Targets to Drug Treatment.
    Menna-Barreto RF; de Castro SL
    Curr Top Med Chem; 2017; 17(10):1212-1234. PubMed ID: 27784255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, structure-activity relationship and in vivo efficacy of piperazine analogues of fenarimol as inhibitors of Trypanosoma cruzi.
    Keenan M; Alexander PW; Diao H; Best WM; Khong A; Kerfoot M; Thompson RC; White KL; Shackleford DM; Ryan E; Gregg AD; Charman SA; von Geldern TW; Scandale I; Chatelain E
    Bioorg Med Chem; 2013 Apr; 21(7):1756-63. PubMed ID: 23462713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives.
    Moreno-Viguri E; Jiménez-Montes C; Martín-Escolano R; Santivañez-Veliz M; Martin-Montes A; Azqueta A; Jimenez-Lopez M; Zamora Ledesma S; Cirauqui N; López de Ceráin A; Marín C; Sánchez-Moreno M; Pérez-Silanes S
    J Med Chem; 2016 Dec; 59(24):10929-10945. PubMed ID: 28002965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs.
    Vázquez K; Paulino M; Salas CO; Zarate-Ramos JJ; Vera B; Rivera G
    Mini Rev Med Chem; 2017; 17(11):939-946. PubMed ID: 28302040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bioactive Trypanosoma cruzi Bromodomain Inhibitor from Chemically Engineered Extracts.
    Ramallo IA; Alonso VL; Rua F; Serra E; Furlan RLE
    ACS Comb Sci; 2018 Apr; 20(4):220-228. PubMed ID: 29481050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.
    Beltran-Hortelano I; Perez-Silanes S; Galiano S
    Curr Med Chem; 2017 May; 24(11):1066-1138. PubMed ID: 28025938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in Chagas Disease Drug Development.
    Francisco AF; Jayawardhana S; Olmo F; Lewis MD; Wilkinson SR; Taylor MC; Kelly JM
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32560454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
    Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
    Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.